ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 positions worth $8.55M for the quarter ended Jun 30, 2026, down 30.4% on the prior quarter. It opened 0 new positions, added to 0, trimmed 1 and exited 0. Its largest holding is Ceribell, Inc. at 62.6% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| CBLL Ceribell, Inc. | -166.5K | -37.7% | $3.24M | 62.61% |
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | CBLL Ceribell, Inc. | Healthcare | 275.3K | $5.36M | 62.61% | -166.5K | -37.7% | Reduced | 0.72% |
| 2 | RPID Rapid Micro Biosystems, Inc. | Healthcare | 1.85M | $3.20M | 37.39% | 0 | 0.0% | Unchanged | 4.07% |
Tip. Select a row to see that position’s full history at ABG-WTT Global Life Science Capital Partners GP.
As of its Q2 2026 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd’s five largest positions were Ceribell, Inc. (CBLL) at 62.6%, Rapid Micro Biosystems, Inc. (RPID) at 37.4% of the reported portfolio.
ABG-WTT Global Life Science Capital Partners GP Ltd reported a 13F portfolio worth $8.55M across 2 positions for Q2 2026. That is down 30.4% from the previous quarter.
Its largest sales by value were Ceribell, Inc. ($3.24M). It exited 0 positions entirely.
From the Form 13F-HR reports ABG-WTT Global Life Science Capital Partners GP Ltd files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.